|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||
| Total for Current Assets | ||||||
| Intangible asset - Website | ||||||
| Total for Long-term assets | ||||||
| Total for ASSETS | ||||||
| Accounts payable | ||||||
| Loan from related party | ||||||
| Deferred Revenue | ||||||
| Total for Current Liabilities | ||||||
| Stockholders' Equity | ||||||
| Common stock, $0.001 par value, 75,000,000 shares authorized; 3,197,375 and 3,060,875 shares issued and outstanding as of June 30, 2026 and September 30, 2025 | ||||||
| Additional Paid-In Capital | ||||||
| Accumulated Surplus /(Deficit) | ||||||
| Total for Stockholders' Equity | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
